Dr. Jennifer Schneider joined Certara in 2019 as Clinical Pharmacologist. In her current role, she engages with clients to provide strategic and scientific expertise to facilitate efficient drug development in a range of disease areas.
Before joining Certara, she served as a Clinical Pharmacologist at Vertex Pharmaceuticals, where she worked in the area of rare disease, providing strategic and quantitative support for the development of multiple therapies. This included aiding in the optimization of drug combinations, pediatric development, and pharmacokinetic and pharmacodynamic analysis. Prior to this assignment, Dr. Schneider obtained her PhD in Pharmaceutical Sciences from the University at Buffalo where her research activities focused on the use of liposomal formulations to improve the pharmacokinetics and mitigate immunogenicity of protein therapeutics.